[email protected] +91 9789129171
IFICI · Registering as Listener

International Forum on Immunology and Clinical Immunotherapy

23 - 24 Jun 2027 Copenhagen, Denmark Standard / Physical Participation
Listener Registration
$115
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceIFICI
ModeStandard / Physical
ParticipationListener
Registration fee$175.00
Bank charges (5.8%)$10.15
Total payable$185.15
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

IFICI conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Advancements in Cancer Immunotherapy +
This track will explore the latest breakthroughs in cancer immunotherapy, focusing on novel therapeutic strategies and their clinical applications. Discussions will include immune checkpoint inhibitors, therapeutic vaccines, and the integration of immunotherapy into standard cancer care.
02 Autoimmune Disease Therapies +
This session will delve into innovative approaches for managing autoimmune diseases through immunotherapeutic interventions. Emphasis will be placed on emerging therapies and their mechanisms of action in modulating immune responses.
03 Monoclonal Antibodies in Clinical Practice +
This track will highlight the role of monoclonal antibodies in the treatment of various diseases, including cancer and autoimmune disorders. Participants will examine the development, efficacy, and safety profiles of these targeted therapies.
04 Adoptive Cell Transfer Techniques +
This session will focus on the methodologies and clinical outcomes associated with adoptive cell transfer therapies, particularly in oncology. The discussion will include T cell engineering, tumor-infiltrating lymphocytes, and CAR T cell therapy.
05 Cytokine Therapy: Mechanisms and Applications +
This track will investigate the role of cytokines in immune modulation and their therapeutic potential in various diseases. Participants will discuss the latest research on cytokine therapies and their implications for clinical practice.
06 Immune Regulation and Tolerance +
This session will explore the mechanisms underlying immune regulation and tolerance, with a focus on their implications for therapy. Topics will include the role of regulatory T cells and the development of tolerance-inducing therapies.
07 Clinical Trials in Immunotherapy +
This track will provide insights into the design and execution of clinical trials focused on immunotherapeutic agents. Participants will discuss challenges, regulatory considerations, and strategies for successful trial outcomes.
08 Translational Medicine in Immunology +
This session will highlight the translation of basic immunological research into clinical applications. Emphasis will be placed on bridging the gap between laboratory findings and patient care.
09 Immune Biomarkers in Disease Management +
This track will examine the role of immune biomarkers in diagnosing and monitoring disease progression and treatment response. Discussions will include the identification and validation of biomarkers in clinical settings.
10 Cellular and Humoral Immunity: Interplay and Implications +
This session will explore the interactions between cellular and humoral immunity and their significance in health and disease. Participants will discuss how these immune responses can be harnessed for therapeutic purposes.
11 Immune System Disorders: Pathogenesis and Therapy +
This track will focus on the pathophysiology of various immune system disorders and the therapeutic strategies employed to manage them. Emphasis will be placed on novel treatment modalities and their clinical implications.